NCT06142058View on ClinicalTrials.gov

RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC

RecruitingOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

November 13, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
EvaluationNSCLCTargeted Therapy
Interventions
DIAGNOSTIC_TEST

RecistTM criteria

RecistTM criteria and RECIST criteria were used to evaluate the efficacy of targeted therapy for NSCLC with positive driving gene.

Trial Locations (1)

400042

RECRUITING

Cancer Center, Dapping Hospital, Army Medical Center of PLA, Chongqing

All Listed Sponsors
lead

Xueqin Yang

OTHER